Additional Risk minimisation materials to minimise potential risk associated with the use of medicines. The materials have been assessed and approved by the national competent authority in line with their Marketing Authorisation.
Cyprus
Czech republic
Denmark
Luxembourg
-
Malta
Netherlands
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom